OSCR

Glimepiride alleviates blood-brain barrier disruption and neuroinflammation in mice with intracerebral haemorrhage.

Overview

Authors: Huizhen Zhou1,2, Qingli Wang1,2, Yang Liu1,2, Xiangyu Zhang1,2, Yun Chen1,2, Pingping Guo1,2, V. Wee Yong3, Mengzhou Xue1,2
  1. Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China
  2. Academy of Medical Science, Zhengzhou University, Zhengzhou, China
  3. Hotchkiss Brain Institute and Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
Journal: Annals of medicine, volume 58, issue 1, article 2663133
Dates: published online 27 April 2026; in print December 2026
Type: Research article · Language: English
License: CC BY-NC
Identifiers: DOI 10.1080/07853890.2026.2663133 · PMID 42046441 · PMCID PMC13126947 · OpenAlex W7156608022
Open access: gold, a free copy (OpenAlex)
Categories: histology / microscopy (modality), mouse (organism), stroke (population), cellular / molecular (subfield)
Methods: Connectivity, Statistics
Keywords: Glimepiride, intracerebral haemorrhage, blood-brain barrier, neuroinflammation, apoptosis
MeSH: Blood-Brain Barrier*, Cerebral Hemorrhage*, Neuroinflammatory Diseases*, Neuroprotective Agents*, Animals, Apoptosis, Brain Edema, Disease Models, Animal, Male, Matrix Metalloproteinase 9, Mice, Mice, Inbred C57BL, Occludin, Sulfonylurea Compounds, Zonula Occludens-1 Protein (* major topic)
Journal subjects: Neurology
Topic: Intracerebral and Subarachnoid Hemorrhage Research (Clinical Neurology, Medicine), according to OpenAlex
Funding: National Natural Science Foundation of China (82071331, 81870942)
Citations: cited by 1 paper (Europe PMC); 67 references in the paper

Abstract

Background: Intracerebral haemorrhage (ICH) is characterised by high mortality and lethality with no effective treatment. Studying the pathophysiological mechanism of brain injury after ICH is expected to improve prognosis. Glimepiride (GPD) has neuroprotective effects in ischaemic stroke and Parkinson’s disease models. However, it is unclear whether GPD effectively reduces brain injury after ICH. Therefore, we evaluated GPD in acute brain injury in ICH mice and assessed its potential mechanisms.

Methods: C57BL/6 mice were injected with collagenase into the right striatum to induce ICH, and were euthanized after 3 days of GPD treatment (4 mg/kg/day). Brain tissues around the haematoma were collected for Western blot and microscopy analyses. The corner turn test, forelimb placing test and modified Garcia test were used to assess neurological functions during life.

Results: The effectiveness of GPD was demonstrated by improved neurological functions, decreased brain oedema and reduced haematoma volume. GPD upregulated ZO-1 and occludin expression while downregulating MMP-9, indicating that GPD protected the integrity of the blood-brain barrier. This was corroborated by the reduction of albumin and Evans blue leakage into the brain parenchyma of GPD-treated mice. Moreover, the anti-inflammatory efficacy of GPD was suggested by reduced Iba-1 and myeloperoxidase immunohistochemistry. GPD also decreased neuronal apoptosis, as evidenced by the upregulation of BCL-2, downregulation of BAX, and decreased number of TUNEL-positive cells.

Conclusion: In ICH injury, GPD protects the integrity of the blood-brain barrier, alleviates neuroinflammation, improves neurological functions, mitigates brain oedema, lessens haematoma volume, and inhibits the apoptosis of neural cells.

Reproduced under the paper's license (CC BY-NC), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability statement

The original data generated in this study are included in the article/Supplementary Material and further inquiries can be directed to the corresponding authors.

Reproduced under the paper's license (CC BY-NC), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 30 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 8 authors, 5 keywords, 15 MeSH terms, 1 funder, 67 references.

Cite

This paper

Zhou, H., Wang, Q., Liu, Y., Zhang, X., Chen, Y., Guo, P., Yong, V. W., & Xue, M. (2026). Glimepiride alleviates blood-brain barrier disruption and neuroinflammation in mice with intracerebral haemorrhage. Annals of medicine, 58(1), 2663133. https://doi.org/10.1080/07853890.2026.2663133

BibTeX

@article{zhou2026glimepiride,
author = {Zhou, Huizhen and Wang, Qingli and Liu, Yang and Zhang, Xiangyu and Chen, Yun and Guo, Pingping and Yong, V. Wee and Xue, Mengzhou},
title = {{Glimepiride alleviates blood-brain barrier disruption and neuroinflammation in mice with intracerebral haemorrhage}},
journal = {Annals of medicine},
year = {2026},
month = apr,
volume = {58},
number = {1},
pages = {2663133},
publisher = {Taylor \& Francis},
issn = {0785-3890},
doi = {10.1080/07853890.2026.2663133},
url = {https://doi.org/10.1080/07853890.2026.2663133},
pmid = {42046441},
pmcid = {PMC13126947}
}

RIS

TY - JOUR
AU - Zhou, Huizhen
AU - Wang, Qingli
AU - Liu, Yang
AU - Zhang, Xiangyu
AU - Chen, Yun
AU - Guo, Pingping
AU - Yong, V. Wee
AU - Xue, Mengzhou
TI - Glimepiride alleviates blood-brain barrier disruption and neuroinflammation in mice with intracerebral haemorrhage
T2 - Annals of medicine
J2 - Ann Med
PY - 2026
DA - 2026/04/27
VL - 58
IS - 1
SP - 2663133
SN - 0785-3890
PB - Taylor & Francis
DO - 10.1080/07853890.2026.2663133
UR - https://doi.org/10.1080/07853890.2026.2663133
LA - en
ER -

CSL-JSON

{
"id": "10.1080/07853890.2026.2663133",
"type": "article-journal",
"title": "Glimepiride alleviates blood-brain barrier disruption and neuroinflammation in mice with intracerebral haemorrhage",
"container-title": "Annals of medicine",
"author": [
{
"family": "Zhou",
"given": "Huizhen"
},
{
"family": "Wang",
"given": "Qingli"
},
{
"family": "Liu",
"given": "Yang"
},
{
"family": "Zhang",
"given": "Xiangyu"
},
{
"family": "Chen",
"given": "Yun"
},
{
"family": "Guo",
"given": "Pingping"
},
{
"family": "Yong",
"given": "V. Wee"
},
{
"family": "Xue",
"given": "Mengzhou"
}
],
"container-title-short": "Ann Med",
"volume": "58",
"issue": "1",
"page": "2663133",
"DOI": "10.1080/07853890.2026.2663133",
"PMID": "42046441",
"PMCID": "PMC13126947",
"ISSN": "0785-3890",
"publisher": "Taylor & Francis",
"URL": "https://doi.org/10.1080/07853890.2026.2663133",
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
27
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.3389/fnmol.2022.916249
Necrosulfonamide Alleviates Acute Brain Injury of Intracerebral Hemorrhage <i>via</i> Inhibiting Inflammation and Necroptosis.
Journal: Frontiers in molecular neuroscience
In common: stroke, mouse, cellular / molecular, 8 references
[2] doi:10.3390/ijms25031438
TonEBP: A Key Transcription Factor in Microglia Following Intracerebral Hemorrhage Induced-Neuroinflammation.
Journal: International journal of molecular sciences
In common: stroke, mouse, cellular / molecular, 4 references
[3] doi:10.3389/fphar.2022.850060
Zhilong Huoxue Tongyu Capsules Ameliorate Early Brain Inflammatory Injury Induced by Intracerebral Hemorrhage <i>via</i> Inhibition of Canonical NFкβ Signalling Pathway.
Journal: Frontiers in pharmacology
In common: stroke, histology / microscopy, mouse, 1 other category, 3 references
[4] doi:10.1186/s12987-022-00312-4
The blood-brain barrier and the neurovascular unit in subarachnoid hemorrhage: molecular events and potential treatments.
Journal: Fluids and barriers of the CNS
In common: stroke, cellular / molecular, 3 references
[5] doi:10.1038/s41598-024-71132-9
TYROBP serve as potential immune-related signature genes in the acute phase of intracerebral hemorrhage.
Journal: Scientific reports
In common: stroke, mouse, cellular / molecular, 3 references
[6] doi:10.3389/fimmu.2022.919444
Role of complement C1q/C3-CR3 signaling in brain injury after experimental intracerebral hemorrhage and the effect of minocycline treatment.
Journal: Frontiers in immunology
In common: stroke, mouse, 3 references
[7] doi:10.1538/expanim.22-0145
FERM domain containing kindlin 1 knockdown attenuates inflammation induced by intracerebral hemorrhage in rats via NLR family pyrin domain containing 3/nuclear factor kappa B pathway.
Journal: Experimental animals
In common: stroke, cellular / molecular, 3 references
[8] doi:10.1093/brain/awaf435 [code]
SUR1-TRPM4 is expressed in human epilepsy and promotes neuron hyperactivity and seizures in rodents.
Journal: Brain : a journal of neurology
In common: histology / microscopy, mouse, cellular / molecular, 2 references
[9] doi:10.1186/s12974-023-02907-6
Receptor-interacting protein kinase 2 (RIPK2) profoundly contributes to post-stroke neuroinflammation and behavioral deficits with microglia as unique perpetrators.
Journal: Journal of neuroinflammation
In common: stroke, histology / microscopy, mouse, 1 other category, 2 references
[10] doi:10.1186/s12974-022-02533-8
Targeted BRD4 protein degradation by dBET1 ameliorates acute ischemic brain injury and improves functional outcomes associated with reduced neuroinflammation and oxidative stress and preservation of blood-brain barrier integrity.
Journal: Journal of neuroinflammation
In common: stroke, mouse, cellular / molecular, 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.